MSAID on ASBMB 2022

We are excited to attend the 14th International Symposium on Mass Spectrometry in the Health and Life Sciences from August 14th until 18th in Cambridge.

Poster and Oral Presentation at ASBMB:

• An AI-driven leap forward in peptide identification through deconvolution of chimeric spectra
  Chimeric spectra are estimated to constitute >40% of DDA data, violating the assumption that one spectrum represents one peptide. Here, we describe a new intelligent search algorithm (CHIMERYS) that rethinks the analysis of tandem mass spectra from the ground up. It routinely doubles the number of peptide identifications and reaches identification rates of >80%.

The oral presentation will be on Monday, August 15th in the afternoon session.

We look forward to meeting you personally! Follow us on Twitter @msaid_de and LinkedIn for live updates.